Detalles de la búsqueda
1.
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.
Eur J Haematol
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693677
2.
Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project.
Breast Cancer Res Treat
; 175(3): 701-712, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30868393
3.
Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients.
Leuk Lymphoma
; 64(2): 478-482, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423347
4.
Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumours.
Eur J Cancer
; 44(16): 2444-52, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18804996
Resultados
1 -
4
de 4
1
Próxima >
>>